Navigation Links
Boston Scientific Announces Schedule for ACC 2008
Date:3/25/2008

Failure Patients. Bruce

Koplan, M.D., will present a meta-analysis comparing bi-ventricular

pacing percentages and its impact on the combined risk of death and

heart failure hospitalization. The results will be presented at 9:00

a.m., during an oral abstract session in Room S403.

Tuesday, April 1

-- TAXUS Stent in Large Vessels. David A. Cox, M.D., will present an

analysis of data from the TAXUS IV & V randomized clinical trials

comparing the outcomes of drug-eluting stents versus bare-metal stents

in patients with large vessels. The results will be presented at

8:30 a.m., during an oral abstract session in Room S103d.

-- TAXUS IV/V Diabetic data. Gregg W. Stone, M.D., will present

three-year results from a pooled analysis of the TAXUS IV & V clinical

trials, including angiographic and IVUS outcomes at nine months and

clinical outcomes at three years for 317 diabetic patients and 862

non-diabetic patients. The goal of the study is to determine if

diabetes is a risk factor for restenosis and adverse clinical outcomes

in patients treated with the TAXUS Stent. The results will be

presented at 9:31 a.m., during an oral abstract session in Room S103d.

The Company plans to issue a press release at this time.

-- TAXUS Stent TLR meta-analysis. Stephen G. Ellis, M.D., will present a

meta-analysis of long-term follow-up data from more than 1,300 patients

in the TAXUS clinical trial program with up to five years of follow-up.

The study is designed to determine predictors of target lesion

revascularization (TLR) and long-term outcomes in drug-eluting stent

patients who develop in-stent restenosis. The results will be

presented at 9:43 a.m., during an oral abstract session in Room S103d.

The Company plans to issue a press release at this t
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Boston Biomedical Research Institute Maintains Baa3 Rating from Moodys
2. Boston College, MIT researchers achieve dramatic increase in thermoelectric efficiency
3. Life Science Industry Awards to Be Announced June 3, 2008 in Boston
4. Evotec to Present at the Cowen and Company 28th Annual Health Care Conference in Boston
5. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
6. Boston Scientific to Participate in Lehman Brothers Health Care Conference
7. Boston Scientific Announces European Approval of New Heart Failure Lead
8. BioSpace Boston Career Fair Attracts over 900 Bioscience Candidates
9. Boston Scientific Announces Addition to Clinical Sciences Organization
10. Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
11. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... The report expects global cell isolation ... It also provides a carefully analyzed data about the ... the market. , Full Copy of Report @ ... market for cell expansion will keep witnessing growth at ... growth to be driven by rapid technological advancements, government ...
(Date:12/24/2014)... 23, 2014 China Biologic Products, Inc. ... leading fully integrated plasma-based biopharmaceutical company in ... majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd., ... the China Food and Drug Administration (the "CFDA") ... previously disclosed in the Company,s public filings, the ...
(Date:12/24/2014)... 2014 PharmaBoardroom,s new report, ... and available for free download , digs deep into ... growth in the sector today. One area where ... been in developing a homegrown pharmaceutical manufacturing base, even if ... remains some way off. A cursory comparison with neighboring ...
(Date:12/24/2014)... 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... a Clinical Trial Application (CTA) with the ... (MHRA) seeking regulatory approval to initiate clinical trials for ... Contingent on the Company receiving CTA regulatory ... trial to assess the safety, tolerability and dose escalation ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... Inc. (Nasdaq: NBIX ) today announced its financial results ... For the fourth quarter of 2010, the Company reported net ... a net loss of $7.9 million, or $0.20 per basic share, ... 31, 2010, the Company reported a net loss of $8.0 million, ...
... ROCKVILLE, Md., Feb. 10, 2011 Novavax, Inc. (Nasdaq: ... today that Dr. Rahul Singhvi, President and Chief Executive ... Annual BIO CEO & Investor Conference on February 15th, ... Biotechnology Industry Organization (BIO), the 13th Annual BIO CEO ...
... nanoparticles and graphene results in a more durable catalytic material ... the Journal of the American Chemical Society. The catalytic material ... The researchers are confident the results will help improve fuel ... energy technology, but cost and durability are big challenges," said ...
Cached Biology Technology:Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 2Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 3Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 4Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 5Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 6Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 7A paperweight for platinum 2A paperweight for platinum 3
(Date:12/22/2014)... , Dec. 22, 2014  The 2014 Holiday ... biometrics industry as Acuity Market Intelligence reports that ... finally be open. Acuity forecasts that intensifying demand ... that incorporate biometrics will drive a global market ... biometric devices by 2020.   According ...
(Date:12/17/2014)... 2014 Research and Markets ( ... "Samsung Galaxy S5 - Home Button Synaptics ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... technology than the iPhone 5S, Samsung introduces for ... product. The Galaxy S5 home button ...
(Date:12/17/2014)... Dec. 16, 2014  Automation is fundamentally transforming ... evident than at international borders. Over the past ... have allowed veteran travelers to self process through ... (APC) Kiosks at an increasing number of airports, ... According to Maxine Most , ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... 10, 2009)Interventional radiologists are fitting together the puzzle pieces ... or more blood vessels to treat peripheral arterial disease ... arteries. That puzzle may be closer to being solved ... imaging to view and locate transplanted stem cells and ...
... DIEGO, Calif. (March 10, 2009)The use of common and ... with traditional risk scoring systemssuch as the Framingham Risk ... thousands of individuals who are not originally thought to ... researchers at the Society of Interventional Radiology,s 34th Annual ...
... Jim Pathman Oversees Software Development, Operations, Information Technology ... Analytics, Inc., the leader in on-demand identity intelligence, ... company as its chief information officer. Pathman is ... 20-year track record of using leading edge technology ...
Cached Biology News:'Seeing' stem cells helps in fight against peripheral arterial disease 2'Seeing' stem cells helps in fight against peripheral arterial disease 3'Seeing' stem cells helps in fight against peripheral arterial disease 4Simple test helps predict heart attack risk 2Simple test helps predict heart attack risk 3ID Analytics Appoints Chief Information Officer 2